Effect of follicular diameter at the time of ovulation triggering on pregnancy outcomes during intrauterine insemination

Int J Gynaecol Obstet. 2017 Nov;139(2):174-179. doi: 10.1002/ijgo.12291. Epub 2017 Aug 28.

Abstract

Objective: To compare pregnancy outcomes when triggering ovulation at different follicle sizes during intrauterine insemination (IUI) cycles.

Methods: A prospective observational study was undertaken at two collaborative fertility centers in Saudi Arabia between January 2014 and May 2016. Women of any age were enrolled if they met inclusion criteria: primary, secondary, or unexplained infertility (≥1 year); day-2 follicle-stimulating hormone less than 12 IU/mL; normal prolactin, thyroid function, and uterine cavity; at least one patent tube; and a male partner with normal semen count and motility. IUI cycles were subdivided by size of dominant follicle (17 to <18 mm, 18 to <19 mm, 19 to <20 mm, and ≥20 mm), and pregnancy outcomes compared.

Results: Data from 516 IUI cycles were analyzed. Frequencies of clinical pregnancy, ongoing pregnancy, and live birth for a follicle size of 19-20 mm were 30.2% (39/129), 24.0% (31/129), and 24.0% (31/129), respectively; these rates were significantly higher than those in other groups (all P<0.05). Only endometrial thickness was found to also contribute to outcome: probability of pregnancy increased as thickness rose (odds ratio 1.148, 95% confidence interval 1.065-1.237; P<0.001).

Conclusion: The optimal follicular diameter associated with increased pregnancy rates in gonadotropin-stimulated IUI cycles was between 19 and 20 mm.

Keywords: Endometrial thickness; Follicle size; Gonadotropin stimulation; Intrauterine insemination; Ovulation induction; Pregnancy outcomes.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Chorionic Gonadotropin / administration & dosage
  • Drug Administration Schedule
  • Female
  • Humans
  • Insemination, Artificial*
  • Male
  • Ovarian Follicle / diagnostic imaging*
  • Ovarian Follicle / drug effects
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies

Substances

  • Chorionic Gonadotropin